?Effect of febuxostat against coronavirus

Phase 3

• Conditions: COVID-19.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20190727044343N1
• Lead Sponsor: Mazandaran University of Medical Sceinces

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients infected with COVID-19

Exclusion Criteria

Severe disease patients that need hospitalization.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CT-scan findings. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: CT-scan.

Secondary Outcome Measures

Name	Time	Method
Fever. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: Thermometer.;Lymphocyte count. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: CBC test.;CRP. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: Laboratory.